The Enterprise Value as of December 2025 (TTM) for Stayble Therapeutics AB (publ) (STABL.ST) is 14.10M

According to Stayble Therapeutics AB (publ)’s latest financial reports and current stock price. The company's current Enterprise Value is 14.10M. This represents a change of -29.61% compared to the average of 20.03M of the last 4 quarters.

Stayble Therapeutics AB (publ) (STABL.ST) Historical Enterprise Value (quarterly & annually)

How has STABL.ST Enterprise Value performed in the past?

The mean historical Enterprise Value of Stayble Therapeutics AB (publ) over the last ten years is 44.56M. The current 14.10M Enterprise Value has changed 3.07% with respect to the historical average. Over the past ten years (40 quarters), STABL.ST's Enterprise Value was at its highest in in the September 2023 quarter at 134.67M. The Enterprise Value was at its lowest in in the December 2023 quarter at -3617748.39.

Stayble Therapeutics AB (publ) (STABL.ST) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Stayble Therapeutics AB (publ) Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Stayble Therapeutics AB (publ) (STABL.ST) Average Enterprise Value

How has STABL.ST Enterprise Value performed in the past?

The current Enterprise Value of Stayble Therapeutics AB (publ) (STABL.ST) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Stayble Therapeutics AB (publ) (STABL.ST) Enterprise Value vs. Peers

How is STABL.ST’s Enterprise Value compared to its peers?

Stayble Therapeutics AB (publ)’s Enterprise Value is less than Fluicell AB (publ) (14.26M), less than Aptahem AB (publ) (14.45M), greater than LIDDS AB (publ) (5.09M), greater than Spermosens AB (9.68M), greater than Chordate Medical Holding AB (publ) (-1031192.00), greater than Quia Pharma AB (publ) (1.57M), greater than 2cureX AB (publ) (13.64M), greater than Guard Therapeutics International AB (publ) (-40816450.00), greater than S2Medical AB (publ) (7.58M), greater than Prostatype Genomics AB (publ) (7.17M),

Build a custom stock screener for Stayble Therapeutics AB (publ) (STABL.ST) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Stayble Therapeutics AB (publ) using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Stayble Therapeutics AB (publ) (STABL.ST) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Stayble Therapeutics AB (publ) or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.